CoChat

Direct interaction of Plk4 with STIL ensures formation of a single procentriole per parental centriole

Open access
Ohta, Midori, Ashikawa, Tomoko, Nozaki, Yuka, Kozuka-Hata, Hiroko, Goto, Hidemasa, Inagaki, Masaki, Oyama, Masaaki, Kitagawa, Daiju · 2014 · Nature Communications

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Abstract

Formation of one procentriole next to each pre-existing centriole is essential for centrosome duplication, robust bipolar spindle assembly and maintenance of genome integrity. However, the mechanisms maintaining strict control over centriole copy number are incompletely understood. Here we show that Plk4 and STIL, the key regulators of centriole formation, form a protein complex that provides a scaffold for recruiting HsSAS-6, a major component of the centriolar cartwheel, at the onset of procentriole formation. Furthermore, we demonstrate that phosphorylation of STIL by Plk4 facilitates the STIL/HsSAS-6 interaction and centriolar loading of HsSAS-6. We also provide evidence that negative feedback by centriolar STIL regulates bimodal centriolar distribution of Plk4 and seemingly restricts occurrence of procentriole formation to one site on each parental centriole. Overall, these findings suggest a mechanism whereby coordinated action of three critical factors ensures formation of a single procentriole per parental centriole.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/ncomms6267

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Direct interaction of Plk4 with STIL is required for centriolar targeting of STIL and centriole formation. (a) Co-immunoprecipitation (co-IP) assays testing interactions between the indicated Plk4-FLAG proteins and endogenous STIL. HEK293T cells expressing the empty FLAG vector (–), FLAG-tagged Plk4 full-length (FL) wild-type (FL-WT), FL kinase dead (FL-KD), ΔPEST (Δ272–311 a.a.) WT (ΔP-WT) or ΔPEST KD (ΔP-KD) were immunoprecipitated (IP) with FLAG antibodies. Total cell lysates and IPs were analysed by western blotting using STIL, HsSAS-6, FLAG or tubulin antibodies. (b) Schematic of HA-tagged STIL FL and deletion constructs used for co-IP assays with Plk4ΔPEST-FLAG in HEK293T cells. The right columns show a summary of the co-IP results and centriolar localization of the STIL constructs examined in U2OS cells. The STIL constructs that interact with Plk4ΔPEST-FLAG are represented in red and the minimal binding region in light green. The evolutionarily conserved coiled-coil (CC: a.a. 721–746) and STAN (a.a. 1,061–1,147) domains are indicated. ND, not determined. (c) Alignment of the CC domain within human, mouse, Xenopus and zebrafish STIL and Drosophila Ana2. Identical residues are coloured in yellow; similar residues in grey. Asterisks indicate the residues identical in all aligned sequences; colons: conserved substitutions; periods: semi-conserved substitutions. (d) HEK293T cells co-expressing Plk4ΔPEST-FLAG and HA-STIL FL or STILΔCC were IP with FLAG antibodies. Total cell lysates and IPs were analysed by western blotting using the indicated antibodies. (e) Yeast two-hybrid assay testing interactions between FL or the indicated fragment (a.a. 661–1,017) of STIL and WT or KD Plk4. The empty vectors (–) were used for negative controls. Two independent clones were grown on the plates without histidine and containing 50 mM 3-AT (Supplementary Fig. 1g). (f) U2OS cells were treated with control siRNA (siCnt) or siRNA targeting 3′UTR of endogenous STIL (siSTIL), followed by transfection with an empty vector (vec; –), HA-STIL FL, N-terminal fragment (N), ΔCC or C-terminal fragment (C). The cells were immunostained with antibodies against HA and centrin. DNA is shown in blue. Insets show approximately fivefold magnified views around the centrosome. Scale bar, 5 μm. Histograms represent frequency of interphase cells with centriolar HA (top) or with ≥4 centrin foci (bottom) in each condition. Values are mean percentages±s.d. from three independent experiments (N>50 for each condition). *P<0.05, **P<0.01, NS, not significant (one-tailed t-test).
Figure 1 Direct interaction of Plk4 with STIL is required for centriolar targeting of STIL and centriole formation. (a) Co-immunoprecipitation (co-IP) assays testing interactions between the indicated Plk4-FLAG proteins and endogenous STIL. HEK293T cells expressing the empty FLAG vector (–), FLAG-tagged Plk4 full-length (FL) wild-type (FL-WT), FL kinase dead (FL-KD), ΔPEST (Δ272–311 a.a.) WT (ΔP-WT) or ΔPEST KD (ΔP-KD) were immunoprecipitated (IP) with FLAG antibodies. Total cell lysates and IPs were analysed by western blotting using STIL, HsSAS-6, FLAG or tubulin antibodies. (b) Schematic of HA-tagged STIL FL and deletion constructs used for co-IP assays with Plk4ΔPEST-FLAG in HEK293T cells. The right columns show a summary of the co-IP results and centriolar localization of the STIL constructs examined in U2OS cells. The STIL constructs that interact with Plk4ΔPEST-FLAG are represented in red and the minimal binding region in light green. The evolutionarily conserved coiled-coil (CC: a.a. 721–746) and STAN (a.a. 1,061–1,147) domains are indicated. ND, not determined. (c) Alignment of the CC domain within human, mouse, Xenopus and zebrafish STIL and Drosophila Ana2. Identical residues are coloured in yellow; similar residues in grey. Asterisks indicate the residues identical in all aligned sequences; colons: conserved substitutions; periods: semi-conserved substitutions. (d) HEK293T cells co-expressing Plk4ΔPEST-FLAG and HA-STIL FL or STILΔCC were IP with FLAG antibodies. Total cell lysates and IPs were analysed by western blotting using the indicated antibodies. (e) Yeast two-hybrid assay testing interactions between FL or the indicated fragment (a.a. 661–1,017) of STIL and WT or KD Plk4. The empty vectors (–) were used for negative controls. Two independent clones were grown on the plates without histidine and containing 50 mM 3-AT (Supplementary Fig. 1g). (f) U2OS cells were treated with control siRNA (siCnt) or siRNA targeting 3′UTR of endogenous STIL (siSTIL), followed by transfection with an empty vector (vec; –), HA-STIL FL, N-terminal fragment (N), ΔCC or C-terminal fragment (C). The cells were immunostained with antibodies against HA and centrin. DNA is shown in blue. Insets show approximately fivefold magnified views around the centrosome. Scale bar, 5 μm. Histograms represent frequency of interphase cells with centriolar HA (top) or with ≥4 centrin foci (bottom) in each condition. Values are mean percentages±s.d. from three independent experiments (N>50 for each condition). *P<0.05, **P<0.01, NS, not significant (one-tailed t-test).CC BY · PubMed Central
Figure 2 Plk4 kinase activity promotes the formation of a complex between STIL and HsSAS-6. (a) U2OS cells were treated with control siRNA or siRNA targeting 3′UTR of endogenous STIL, followed by transfection with an empty vector (–), HA-STIL full-length (FL), N (a.a. 1–1,017) or ΔSTAN (Δ1,061–1,147 a.a.). The cells were fixed and immunostained with antibodies against HA and HsSAS-6. DNA is shown in blue. Histograms represent frequency of interphase cells with centriolar HA (top) or with centriolar HsSAS-6 (bottom) in each condition. Insets show approximately sevenfold magnified views around the centrosome. Scale bar, 5 μm. Values are mean percentages±s.d. from three independent experiments (N>50 for each condition). *P<0.05, **P<0.01, NS, not significant (one-tailed t-test). (b) HEK293T cells co-expressing Plk4ΔP-FLAG wild type (WT) or kinase-dead (KD) and Myc-HsSAS-6 were immunoprecipitated (IP) with HsSAS-6. The amount of expressed Plk4ΔP-FLAG WT and KD was collected by IP using FLAG beads. Total cell lysates and IPs were analysed by western blotting using STIL, HsSAS-6 or FLAG antibodies. (c–g) In vitro reconstitution of a Plk4-dependent complex formation of STIL and HsSAS-6. (c) Schematic of the method used for monitoring the interaction between Plk4-phosphorylated STIL and HsSAS-6 in vitro. Plk4ΔP-FLAG WT or KD proteins were expressed and purified from HEK293T cell using anti-FLAG beads, followed by incubation with bacterially purified STIL N3C WT or ΔSTAN mutant (in d,e), deletion mutants of STIL C (in f,g) recombinant proteins for in vitro kinase assay. After the kinase reaction, the supernatant was collected and incubated with MBP-HsSAS-6 purified from baculovirus/insect cell expression system, and thereafter pulled down using amylose resin. Input and the protein complexes pulled down with amylose resin were analysed by western blotting using STIL, FLAG, HsSAS-6 and HA antibodies. Asterisks represent cleaved products of GST-HA-STIL C or CS.
Figure 2 Plk4 kinase activity promotes the formation of a complex between STIL and HsSAS-6. (a) U2OS cells were treated with control siRNA or siRNA targeting 3′UTR of endogenous STIL, followed by transfection with an empty vector (–), HA-STIL full-length (FL), N (a.a. 1–1,017) or ΔSTAN (Δ1,061–1,147 a.a.). The cells were fixed and immunostained with antibodies against HA and HsSAS-6. DNA is shown in blue. Histograms represent frequency of interphase cells with centriolar HA (top) or with centriolar HsSAS-6 (bottom) in each condition. Insets show approximately sevenfold magnified views around the centrosome. Scale bar, 5 μm. Values are mean percentages±s.d. from three independent experiments (N>50 for each condition). *P<0.05, **P<0.01, NS, not significant (one-tailed t-test). (b) HEK293T cells co-expressing Plk4ΔP-FLAG wild type (WT) or kinase-dead (KD) and Myc-HsSAS-6 were immunoprecipitated (IP) with HsSAS-6. The amount of expressed Plk4ΔP-FLAG WT and KD was collected by IP using FLAG beads. Total cell lysates and IPs were analysed by western blotting using STIL, HsSAS-6 or FLAG antibodies. (c–g) In vitro reconstitution of a Plk4-dependent complex formation of STIL and HsSAS-6. (c) Schematic of the method used for monitoring the interaction between Plk4-phosphorylated STIL and HsSAS-6 in vitro. Plk4ΔP-FLAG WT or KD proteins were expressed and purified from HEK293T cell using anti-FLAG beads, followed by incubation with bacterially purified STIL N3C WT or ΔSTAN mutant (in d,e), deletion mutants of STIL C (in f,g) recombinant proteins for in vitro kinase assay. After the kinase reaction, the supernatant was collected and incubated with MBP-HsSAS-6 purified from baculovirus/insect cell expression system, and thereafter pulled down using amylose resin. Input and the protein complexes pulled down with amylose resin were analysed by western blotting using STIL, FLAG, HsSAS-6 and HA antibodies. Asterisks represent cleaved products of GST-HA-STIL C or CS.CC BY · PubMed Central
Figure 3 STIL is phosphorylated by Plk4 in vitro and in vivo. (a) Schematic of STIL full length and the summary of Plk4-phosphorylated serine/threonine residues of STIL identified by MS (top, indicated in red) and phospho-specific antibodies (top, indicated in blue; Supplementary Fig. 4a). STIL N3 and C fragments were phosphorylated by Plk4 in vitro (bottom). Recombinant STIL fragments N1 (a.a. 1–360), N2 (a.a. 361–600), N3 (a.a. 601–1,000) and C (a.a. 1,018–1,287) were bacterially purified and were incubated with Plk4ΔP-FLAG proteins purified from HEK293T cells for in vitro kinase assay. The incorporation of [γ-32P] ATP to the substrates was visualized by autoradiography, and the loaded proteins were monitored by Simply Blue Safestaining. CC (coiled-coil): a.a. 721–746; STAN: a.a. 1,061–1,147. Asterisk indicates a mobility shift of STIL C by hyper-phosphorylation. (b) In vitro kinase assay with STIL C fragment and Plk4ΔP-FLAG wild-type (WT) or kinase-dead (KD) as in a. After the kinase reaction, the resulting materials were analysed by western blotting using STIL or FLAG antibodies. Asterisk indicates a mobility shift of STIL C by hyper-phosphorylation. (c) Plk4 phosphorylates STIL at Serine 1061 in vitro. In vitro kinase assay was done as in a with the recombinant STIL C WT or S1061A proteins. The total reaction mixture was analysed by SDS–PAGE, followed by Simply Blue Safestaining or western blotting using antibodies against phospho-S1061. Note that the peptide containing S1061 was too large (53 a.a.) to be detected by MS. We therefore generated a phopho-specific antibody against S1061 to verify the existence of phosphorylation at this site. (d) Phosphatase assay of endogenous STIL in U2OS cells. Cells expressing Plk4ΔP-FLAG WT or KD were just lysed (first two lanes) or further treated with λ-phosphatase (±) (last two lanes). The resulting materials were analysed by western blot using antibodies against STIL or tubulin. The amount of expressed Plk4ΔP-FLAG WT and KD was collected by immunoprecipitate (IP) using FLAG beads, followed by western blot using FLAG antibodies. (e) U2OS cells expressing HA-STIL N3C WT or 7A+5A mutant and Plk4ΔPEST-FLAG WT or KD were lysed and analysed by western blot as in d.
Figure 3 STIL is phosphorylated by Plk4 in vitro and in vivo. (a) Schematic of STIL full length and the summary of Plk4-phosphorylated serine/threonine residues of STIL identified by MS (top, indicated in red) and phospho-specific antibodies (top, indicated in blue; Supplementary Fig. 4a). STIL N3 and C fragments were phosphorylated by Plk4 in vitro (bottom). Recombinant STIL fragments N1 (a.a. 1–360), N2 (a.a. 361–600), N3 (a.a. 601–1,000) and C (a.a. 1,018–1,287) were bacterially purified and were incubated with Plk4ΔP-FLAG proteins purified from HEK293T cells for in vitro kinase assay. The incorporation of [γ-32P] ATP to the substrates was visualized by autoradiography, and the loaded proteins were monitored by Simply Blue Safestaining. CC (coiled-coil): a.a. 721–746; STAN: a.a. 1,061–1,147. Asterisk indicates a mobility shift of STIL C by hyper-phosphorylation. (b) In vitro kinase assay with STIL C fragment and Plk4ΔP-FLAG wild-type (WT) or kinase-dead (KD) as in a. After the kinase reaction, the resulting materials were analysed by western blotting using STIL or FLAG antibodies. Asterisk indicates a mobility shift of STIL C by hyper-phosphorylation. (c) Plk4 phosphorylates STIL at Serine 1061 in vitro. In vitro kinase assay was done as in a with the recombinant STIL C WT or S1061A proteins. The total reaction mixture was analysed by SDS–PAGE, followed by Simply Blue Safestaining or western blotting using antibodies against phospho-S1061. Note that the peptide containing S1061 was too large (53 a.a.) to be detected by MS. We therefore generated a phopho-specific antibody against S1061 to verify the existence of phosphorylation at this site. (d) Phosphatase assay of endogenous STIL in U2OS cells. Cells expressing Plk4ΔP-FLAG WT or KD were just lysed (first two lanes) or further treated with λ-phosphatase (±) (last two lanes). The resulting materials were analysed by western blot using antibodies against STIL or tubulin. The amount of expressed Plk4ΔP-FLAG WT and KD was collected by immunoprecipitate (IP) using FLAG beads, followed by western blot using FLAG antibodies. (e) U2OS cells expressing HA-STIL N3C WT or 7A+5A mutant and Plk4ΔPEST-FLAG WT or KD were lysed and analysed by western blot as in d.CC BY · PubMed Central
Figure 4 Critical sites in the STIL STAN motif for STIL/HsSAS-6 interaction and centriolar targeting of HsSAS-6. (a) Alignment of the STAN motif within human, mouse, Xenopus and zebrafish STIL and Drosophila Ana2. Colours and symbols indicate the same as in Fig. 1c. The S/T sites tested in b are shown in green. S1061 and S1116 are highlighted in red. Grey double lines indicate the critical parts of the STAN motif identified in Supplementary Fig. 2e. (b) Alanine mutational scan for the S/T sites within the STAN motif. In vitro kinase and binding assays were performed as described in Fig. 2c except for using recombinant GST-STIL CS wild-type (WT) or non-phosphorylatable alanine mutants. (c,d) U2OS cells were treated with control siRNA (siCnt) or siRNA targeting 3′UTR of endogenous STIL (siSTIL), followed by transfection with an empty vector (–), HA-STIL WT or non-phosphorylatable mutants, 2A (mutated at S1061 and S1116 to alanine), S1061A and S1116A. The cells were fixed and immunostained with antibodies against HA and centrin (c) or HsSAS-6 (d). DNA is shown in blue. Histograms represent frequency of interphase cells with ≥4 centrioles (c) or with centriolar HsSAS-6 (d) in each condition. Insets show approximately sevenfold magnified views around the centrosome. Scale bar, 5 μm. Values are mean percentages±s.d. from three independent experiments (N>50 for each condition). *P<0.05, **P<0.01; NS, not significant (one-tailed t-test).
Figure 4 Critical sites in the STIL STAN motif for STIL/HsSAS-6 interaction and centriolar targeting of HsSAS-6. (a) Alignment of the STAN motif within human, mouse, Xenopus and zebrafish STIL and Drosophila Ana2. Colours and symbols indicate the same as in Fig. 1c. The S/T sites tested in b are shown in green. S1061 and S1116 are highlighted in red. Grey double lines indicate the critical parts of the STAN motif identified in Supplementary Fig. 2e. (b) Alanine mutational scan for the S/T sites within the STAN motif. In vitro kinase and binding assays were performed as described in Fig. 2c except for using recombinant GST-STIL CS wild-type (WT) or non-phosphorylatable alanine mutants. (c,d) U2OS cells were treated with control siRNA (siCnt) or siRNA targeting 3′UTR of endogenous STIL (siSTIL), followed by transfection with an empty vector (–), HA-STIL WT or non-phosphorylatable mutants, 2A (mutated at S1061 and S1116 to alanine), S1061A and S1116A. The cells were fixed and immunostained with antibodies against HA and centrin (c) or HsSAS-6 (d). DNA is shown in blue. Histograms represent frequency of interphase cells with ≥4 centrioles (c) or with centriolar HsSAS-6 (d) in each condition. Insets show approximately sevenfold magnified views around the centrosome. Scale bar, 5 μm. Values are mean percentages±s.d. from three independent experiments (N>50 for each condition). *P<0.05, **P<0.01; NS, not significant (one-tailed t-test).CC BY · PubMed Central
Figure 5 Bimodal centriolar distribution of Plk4 across the cell cycle. (a) Centriolar distribution of endogenous Plk4 proteins across the cell cycle. U2OS cells were arrested in prometaphase by treatment with nocodazole for 14 h. The cells were then washed out with fresh media without nocodazole three times and released from the arrest. After the release, the cells were fixed at different phases of the cell cycle and stained with antibodies against Cep152 or STIL as well as Plk4. Insets show ~10-fold magnified views around the centrosome. Scale bar, 5 μm. (b) Quantification of the local signal intensity of centriolar Plk4 and STIL. The local signal intensity was visualized in the indicated colours. The external diameter of centriolar Plk4 rings or dots was measured. Insets show approximately eight-fold magnified views around the centrosome. Scale bar, 5 μm. Values are mean percentages±s.e.m. N, number of total centrosomes. (c) Based on the centriolar distribution of Plk4, centrosomes were placed into two categories (ring-like or dot). The relative representation of each category as well as centriolar STIL over time is shown in the graph. The DNA content of cells for each time point was monitored by flow cytometry (right panels). Values are mean percentages±s.e.m. from four independent experiments for Plk4 (N>60 for each time point) and from two independent experiments for STIL (N>120 for each time point). The schematic represents the typical patterns of centriolar Plk4 and STIL across the cell cycle. (d,e) STIL and HsSAS-6 regulate centriolar distribution of Plk4. (d) U2OS cells were treated with control siRNAs (siCnt) or siRNAs targeting the 3′UTR of HsSAS-6 (siHsSAS-6) or STIL (siSTIL), and stained with antibodies against Plk4 and Cep152. The local signal intensity of centriolar Plk4 was quantified and visualized as indicated (bottom panels). DNA is shown in blue. Insets show approximately ninefold magnified views. Scale bar, 5 μm. (e) Histogram represents percentages of centrosomes categorized based on the centriolar distribution of Plk4. Values are mean percentages±s.e.m. from three independent experiments (N>50 for each condition). For the rescue experiment, U2OS cells treated with siRNAs targeting STIL-3′UTR and expressing HA empty vector (HA), HA-STILΔCC (Δ721–746 a.a.) were stained with antibodies against Plk4 and HA (Supplementary Fig. 7e).
Figure 5 Bimodal centriolar distribution of Plk4 across the cell cycle. (a) Centriolar distribution of endogenous Plk4 proteins across the cell cycle. U2OS cells were arrested in prometaphase by treatment with nocodazole for 14 h. The cells were then washed out with fresh media without nocodazole three times and released from the arrest. After the release, the cells were fixed at different phases of the cell cycle and stained with antibodies against Cep152 or STIL as well as Plk4. Insets show ~10-fold magnified views around the centrosome. Scale bar, 5 μm. (b) Quantification of the local signal intensity of centriolar Plk4 and STIL. The local signal intensity was visualized in the indicated colours. The external diameter of centriolar Plk4 rings or dots was measured. Insets show approximately eight-fold magnified views around the centrosome. Scale bar, 5 μm. Values are mean percentages±s.e.m. N, number of total centrosomes. (c) Based on the centriolar distribution of Plk4, centrosomes were placed into two categories (ring-like or dot). The relative representation of each category as well as centriolar STIL over time is shown in the graph. The DNA content of cells for each time point was monitored by flow cytometry (right panels). Values are mean percentages±s.e.m. from four independent experiments for Plk4 (N>60 for each time point) and from two independent experiments for STIL (N>120 for each time point). The schematic represents the typical patterns of centriolar Plk4 and STIL across the cell cycle. (d,e) STIL and HsSAS-6 regulate centriolar distribution of Plk4. (d) U2OS cells were treated with control siRNAs (siCnt) or siRNAs targeting the 3′UTR of HsSAS-6 (siHsSAS-6) or STIL (siSTIL), and stained with antibodies against Plk4 and Cep152. The local signal intensity of centriolar Plk4 was quantified and visualized as indicated (bottom panels). DNA is shown in blue. Insets show approximately ninefold magnified views. Scale bar, 5 μm. (e) Histogram represents percentages of centrosomes categorized based on the centriolar distribution of Plk4. Values are mean percentages±s.e.m. from three independent experiments (N>50 for each condition). For the rescue experiment, U2OS cells treated with siRNAs targeting STIL-3′UTR and expressing HA empty vector (HA), HA-STILΔCC (Δ721–746 a.a.) were stained with antibodies against Plk4 and HA (Supplementary Fig. 7e).CC BY · PubMed Central
Figure 6 The interaction of Plk4 with STIL regulates the bimodal distribution of Plk4 around parental centriole. (a,b) U2OS cells were arrested in G1/S phase by treatment with aphidicolin (Aph) for 18 h, followed by addition of 10 μM MG132 (±) for 6 h. Cells were then fixed and stained with antibodies against Plk4 and STIL. DNA is shown in blue. In this figure, all insets show approximately ninefold magnified views around the centrosome. Scale bars, 5 μm. The local signal intensity of centriolar Plk4 and STIL was quantified and visualized as indicated. The percentages of centrosomes with Plk4 rings or Plk4 dots were quantified in b (N≥40 centrosomes with STIL from four independent experiment). Similar experiments were also performed with U2OS cells in G1/S phase using cell cycle synchronization (sync.) with nocodazole (Noc) treatment in b. (c) U2OS cells treated with siRNAs targeting STIL-3′UTR (siSTIL) and expressing HA-STIL full length at low or high levels, ΔSTAN (Δ1,061–1,147 a.a.), 5A non-phosphorylatable mutant, PACT-full length or PACT-ΔCC were stained with antibodies against Plk4 and HA. Note that the signal intensity of centriolar Plk4 ring in the absence of endogenous STIL or HsSAS-6 is relatively higher than that in the case of overexpression of STIL full length or mutants used in this experiment. The experiment was repeated at least three times. (d) Ubiquitination assay. HEK293T cells transfected with the indicated combination of plasmids were treated with 10 μM MG132 (±) for 6 h. The cells were then immunoprecipitated (IP) with FLAG antibodies. Total cell lysate and IPs were analysed by western blotting using Myc, FLAG, STIL or tubulin antibodies. (e) HEK293T cells co-expressing Plk4ΔPEST-FLAG wild-type or the kinase dead (KD) and HA-STIL full length or STILΔN3 were IP with FLAG antibodies. Total cell lysate and IPs were analysed by western blotting using STIL, FLAG or tubulin antibodies. The values on the bottom indicate the relative amount of IP Plk4ΔPEST-FLAG. Values are mean percentages±s.e.m. from three independent experiments.
Figure 6 The interaction of Plk4 with STIL regulates the bimodal distribution of Plk4 around parental centriole. (a,b) U2OS cells were arrested in G1/S phase by treatment with aphidicolin (Aph) for 18 h, followed by addition of 10 μM MG132 (±) for 6 h. Cells were then fixed and stained with antibodies against Plk4 and STIL. DNA is shown in blue. In this figure, all insets show approximately ninefold magnified views around the centrosome. Scale bars, 5 μm. The local signal intensity of centriolar Plk4 and STIL was quantified and visualized as indicated. The percentages of centrosomes with Plk4 rings or Plk4 dots were quantified in b (N≥40 centrosomes with STIL from four independent experiment). Similar experiments were also performed with U2OS cells in G1/S phase using cell cycle synchronization (sync.) with nocodazole (Noc) treatment in b. (c) U2OS cells treated with siRNAs targeting STIL-3′UTR (siSTIL) and expressing HA-STIL full length at low or high levels, ΔSTAN (Δ1,061–1,147 a.a.), 5A non-phosphorylatable mutant, PACT-full length or PACT-ΔCC were stained with antibodies against Plk4 and HA. Note that the signal intensity of centriolar Plk4 ring in the absence of endogenous STIL or HsSAS-6 is relatively higher than that in the case of overexpression of STIL full length or mutants used in this experiment. The experiment was repeated at least three times. (d) Ubiquitination assay. HEK293T cells transfected with the indicated combination of plasmids were treated with 10 μM MG132 (±) for 6 h. The cells were then immunoprecipitated (IP) with FLAG antibodies. Total cell lysate and IPs were analysed by western blotting using Myc, FLAG, STIL or tubulin antibodies. (e) HEK293T cells co-expressing Plk4ΔPEST-FLAG wild-type or the kinase dead (KD) and HA-STIL full length or STILΔN3 were IP with FLAG antibodies. Total cell lysate and IPs were analysed by western blotting using STIL, FLAG or tubulin antibodies. The values on the bottom indicate the relative amount of IP Plk4ΔPEST-FLAG. Values are mean percentages±s.e.m. from three independent experiments.CC BY · PubMed Central
Figure 7 Model suggesting how the formation of a single procentriole per each parental centriole is controlled. Direct association of STIL with Plk4 and STIL phosphorylation by Plk4 occur at the onset of centriole formation. Phosphorylated STIL directly binds to HsSAS-6, which leads to centriolar loading of HsSAS-6 for cartwheel assembly. Centriolar loading of the STIL/HsSAS-6 complex limits centriolar distribution of Plk4 to one site per each parental centriole. This coordinated action could ensure formation of a single procentriole per each parental centriole and, concurrently, inhibit formation of another procentriole.
Figure 7 Model suggesting how the formation of a single procentriole per each parental centriole is controlled. Direct association of STIL with Plk4 and STIL phosphorylation by Plk4 occur at the onset of centriole formation. Phosphorylated STIL directly binds to HsSAS-6, which leads to centriolar loading of HsSAS-6 for cartwheel assembly. Centriolar loading of the STIL/HsSAS-6 complex limits centriolar distribution of Plk4 to one site per each parental centriole. This coordinated action could ensure formation of a single procentriole per each parental centriole and, concurrently, inhibit formation of another procentriole.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 244

Metadata

Authors
Ohta, M., Ashikawa, T., Nozaki, Y., Kozuka-Hata, H., Goto, H., Inagaki, M., Oyama, M., & Kitagawa, D.
Affiliations
  • National Institute of Genetics (JP)
  • Aichi Cancer Center Research Institute (JP)
  • Institute of Medical Science, The University of Tokyo (JP)
Corresponding author
Kitagawa, Daiju
Venue
Nature Communications
Published
2014-10-24
Volume
5
Issue
1
Pages
5267-5267
ISSN
2041-1723 (ISSN-L)
OpenAlex
W1978538263
Cited by
238
References
41
Citations by year
2026: 7 · 2025: 18 · 2024: 15 · 2023: 16 · 2022: 21 · 2021: 21 · 2020: 33 · 2019: 32 · 2018: 23 · 2017: 17 · 2016: 18 · 2015: 17
FWCI
8.58
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
Funders
  • Mitsubishi Foundation
  • Japan Society for the Promotion of Science (24590396, 24113005, 14J07468, 24687026)
  • Japan Science and Technology Agency
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
  • Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
Keywords
PLK4, STIL, centrosome duplication, protein complexes, spindle assembly
MeSH terms
Amino Acid Sequence, Animals, Cell Cycle, Cell Line, Centrioles, Humans, Models, Biological, Molecular Sequence Data, Phosphorylation, Protein Binding, Sequence Alignment, Protein Serine-Threonine Kinases, Cell Cycle Proteins, 3' Untranslated Regions, Amino Acid Motifs, RNA, Small Interfering, Immunoprecipitation, Intracellular Signaling Peptides and Proteins, HEK293 Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.